With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient.
Annual awards program recognizes outstanding products and companies that are disrupting healthcare
United under Norstella, each brand’s key solutions and expertise will help life-sciences-focused companies get answers—not just insights—from pipeline to patient
Patient Access Analytics solution combines coverage and claims data to provide a unique view of payer and prescriber behavior—offering instant answers using real-world data—to help patients access lifesaving treatments faster
The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of normalized real-world evidence and market access data sets that support decision-making from pipeline to prescription.
Annual awards program recognizes outstanding health and medical technology products and companies
Report examines the drivers, barriers, and benefits of using real-world data (RWD) and advanced analytics
Panalgo’s IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.
Panalgo’s new Data Science module seamlessly integrates machine-learning techniques to identify new insights for patient care
Panalgo, which conveys “an algorithm for everything,” aligns with company vision of streamlining analytics, enabling pharma, payers, and providers to make more impactful decisions
BHE, a leading healthcare analytics company, has announced the formation of its Strategic Advisory Board. The initial appointments include Peter Neumann, ScD, Director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, and Samy Suissa, PhD, Distinguished James McGill Professor at McGill University. The Strategic Advisory Board will […]
Boston Health Economics (BHE), a leading healthcare self-service analytics company, and Premier Healthcare Solutions, Inc. (Premier), a leading healthcare improvement company, are joining forces to streamline data analytics and more quickly uncover strategies that could improve patient care. Through the partnership, Premier Applied Sciences, the research division of Premier, will offer its gold-standard Premier Healthcare […]
A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database, a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic. The database is a pro bono, cross-industry collaboration. Collaborators include Advarra, Aetion, […]
BHE, an innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transformation Partners (“LTP”). The new funding will accelerate the development and market expansion of BHE’s flagship Instant Health Data (IHD) platform, the market-leading real-world evidence (RWE) analytics solution currently being used by over […]
BHE is pleased to announce a new partnership with OM1 that facilitates the direct licensing of, and access to, OM1’s Disease Registry Databases via BHE’s market-leading real-world evidence (RWE) platform, Instant Health Data (IHD). OM1 maintains clinically rich longitudinal data in several chronic disease areas, including immunology. OM1’s Rheumatoid Arthritis (RA) Registry Database is among […]
Put reliable, rapid analytics in the hands of more people across your organization
